Skip to main content
. 2013 Nov 13;8(11):e80725. doi: 10.1371/journal.pone.0080725

Table 3. Clinical and cytogenetic features of previously published osteoblastomas.

Casea Age/Sex Locationb Diagnosisc Karyotype
5004:1 7/M Vertebra OB 46,XY,+der(15)t(15;20)(p11;p11),der(17)t(17;20)(p11-12;q11),-20
7676:8 34/M Os ilium Aggr OB 52,Y,t(X;11)(q22;p14),+2,del(5)(q22),der(6;8)(p10;q10),+del(9)(q31q33),add(12)(q24),-13,add(13)(p11),add(14)(p?),+16,add(18)(p11),+19,+add(19)(p13),-21,+3mar
8024:16 62/F N/A OB 39-40,XX,der(3;8)dic(3;8)(p25;p11)ins(3;?)(p25;?),der(4)t(4;?22)(p15;q12),r(7),-9,der(11)t(11;12)(p13;q12),-12,-14,add(19)(p13),dic(19;22)(q11;p13),-22/39-40,idem,add(19)(p13)
8416:1 14/F Mandible LCET OB 46,XX,del(1)(q42),t(1;5;17;22)(p32-33;p13;q21;q12)
13047:1 23/F Femur OB 46,XX,t(1;2;14)(q42;q13;q24)
13302:1 12/F Femur Aggr OB 46,XX,t(4;7;14)(q23-25;q31;q31)
a

Previously published karyotypes are indicated by their reference and case numbers in The Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (http://cgap.nci.nih.gov/Chromosomes/Mitelman).

b

N/A = not available.

c

OB = osteoblastoma; Aggr OB = aggressive osteoblastoma; LCET OB = large cell, epithelioid, telangiectatic OB.